NK cell infusion is well-tolerated and shows preliminary efficacy in patients with recurrent hepatocellular carcinoma post-liver transplantation : a phase I trial
NK细胞输注耐受性良好,并在肝移植后复发性肝细胞癌患者中显示出初步疗效:一项I期试验
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07725-x
Yang, Fan; Gong, Yihang; Zheng, Xiaofang; Ni, Beibei; Lu, Jianxi; Chen, Xiaoyan; Cheng, Jintao; Li, Panlong; Du, Cong; Chen, Yunhao; Zhang, Yingcai; Yi, Shuhong; Wang, Guoying; Zhang, Qi; Yang, Yang; Chen, Wenjie